Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-25-017354)

Filing Details

Accession Number:: 0001127602-25-017354
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-12 16:22:39
Reporting Period:: 2025-06-11

Filing Date:: 2025-06-12
Accepted Time:: 2025-06-12 16:22:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	Biological Products, (No Disgnostic Substances) (2836)	813467528

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1821956	Abbas Hussain	C/O Moderna, Inc. 325 Binney Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-06-11	312	$28.00	580	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.